Risk of cardiovascular events and death associated with initiation of SGLT2 inhibitors compared with DPP-4 inhibitors: an analysis from the CVD-REAL 2 multinational cohort study
- Kohsaka, S.
- Lam, C.S.P.
- Kim, D.J.
- Cavender, M.A.
- Norhammar, A.
- Jørgensen, M.E.
- Birkeland, K.I.
- Holl, R.W.
- Franch-Nadal, J.
- Tangri, N.
- Shaw, J.E.
- Ilomäki, J.
- Karasik, A.
- Goh, S.-Y.
- Chiang, C.-E.
- Thuresson, M.
- Chen, H.
- Wittbrodt, E.
- Bodegård, J.
- Surmont, F.
- Fenici, P.
- Kosiborod, M.
- Wilding, J.P.
- Khunti, K.
- Birkeland, K.
- Jørgensen, M.E.
- Lam, C.S.
- Gulseth, H.L.
- Carstensen, B.
- Bollow, E.
- García Rodríguez, L.A.
- Shaw, J.
- Arnold, S.
- Blak, B.T.
- Saathoff, M.
- Noguchi, Y.
- Tan, D.
- Williams, M.
- Lee, H.W.
- Greenbloom, M.
- Kaidanovich-Beilin, O.
- Yeo, K.K.
- Bee, Y.M.
- Khoo, J.
- Koong, A.
- Lau, Y.H.
- Gao, F.
- Tan, W.B.
- Kadir, H.A.
- Ha, K.H.
- Lee, J.
- Chodick, G.
- Melzer-Cohen, C.
- Whitlock, R.
- Cea-Soriano, L.
- Cantero, O.F.
- Menzin, J.A.
- Guthrie, M.
- Ilomaki, J.
- Magliano, D.
- Erakutsi egile guztiak +
ISSN: 2213-8595, 2213-8587
Argitalpen urtea: 2020
Alea: 8
Zenbakia: 7
Orrialdeak: 606-615
Mota: Artikulua